Mari‐Paz Rubio

2.0k total citations
29 papers, 1.7k citations indexed

About

Mari‐Paz Rubio is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Mari‐Paz Rubio has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 7 papers in Oncology. Recurrent topics in Mari‐Paz Rubio's work include Cancer-related Molecular Pathways (6 papers), Glioma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Mari‐Paz Rubio is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Glioma Diagnosis and Treatment (5 papers) and Virus-based gene therapy research (4 papers). Mari‐Paz Rubio collaborates with scholars based in Spain, United States and Germany. Mari‐Paz Rubio's co-authors include David N. Louis, Andreas von Deimling, James F. Gusella, Javier S. Castresana, José M. Almendral, Otmar D. Wiestler, Ann D. Thor, Bernd R. Seizinger, Vijaya Ramesh and Lee B. Jacoby and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Journal of Virology.

In The Last Decade

Mari‐Paz Rubio

29 papers receiving 1.6k citations

Peers

Mari‐Paz Rubio
Rossano Cesari United States
Padmavathy Vanguri United States
Judy S. Crabtree United States
Vincent Hurez United States
Endi Wang United States
Rossano Cesari United States
Mari‐Paz Rubio
Citations per year, relative to Mari‐Paz Rubio Mari‐Paz Rubio (= 1×) peers Rossano Cesari

Countries citing papers authored by Mari‐Paz Rubio

Since Specialization
Citations

This map shows the geographic impact of Mari‐Paz Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari‐Paz Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari‐Paz Rubio more than expected).

Fields of papers citing papers by Mari‐Paz Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari‐Paz Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari‐Paz Rubio. The network helps show where Mari‐Paz Rubio may publish in the future.

Co-authorship network of co-authors of Mari‐Paz Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Mari‐Paz Rubio. A scholar is included among the top collaborators of Mari‐Paz Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari‐Paz Rubio. Mari‐Paz Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meseguer, Salvador, Mari‐Paz Rubio, Begoña Lainez, et al.. (2023). SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication. Frontiers in Microbiology. 14. 6 indexed citations
2.
Meseguer, Salvador & Mari‐Paz Rubio. (2022). mt tRFs, New Players in MELAS Disease. Frontiers in Physiology. 13. 800171–800171. 8 indexed citations
3.
Ureña‐Peralta, Juan R., Rainer Saffrich, Mari‐Paz Rubio, et al.. (2013). A Novel Human Glycoprotein ACA is an Upstream Regulator of Human Hematopoiesis. Bulletin of Experimental Biology and Medicine. 155(4). 536–551. 2 indexed citations
4.
Ureña‐Peralta, Juan R., et al.. (2013). Activation by ACA Induces Pluripotency in Human Blood Progenitor Cells. Bulletin of Experimental Biology and Medicine. 155(4). 552–567. 1 indexed citations
5.
Lledó, Elisa, Joaquı́n Dopazo, Francisco García‐García, et al.. (2012). IL1β Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-κB. Stem Cell Reviews and Reports. 8(3). 905–916. 149 indexed citations
6.
Llamusí, Beatriz, Mari‐Paz Rubio, & Almudena Ramón‐Cueto. (2010). Telomerase protects adult rodent olfactory ensheathing glia from early senescence. Experimental Neurology. 229(1). 54–64. 7 indexed citations
7.
López-Bueno, Alberto, Mari‐Paz Rubio, Nathan Bryant, et al.. (2006). Host-Selected Amino Acid Changes at the Sialic Acid Binding Pocket of the Parvovirus Capsid Modulate Cell Binding Affinity and Determine Virulence. Journal of Virology. 80(3). 1563–1573. 64 indexed citations
8.
Avellaneda-Gómez, Carla, Ángel Ignacio Pérez Gómez, Francisco Martos, et al.. (2000). The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery. European Journal of Anaesthesiology. 17(2). 85–90. 43 indexed citations
9.
Frechilla, Diana, Ricardo Insausti, Ana Garcı́a-Osta, et al.. (2000). Implanted BDNF-producing fibroblasts prevent neurotoxin-induced serotonergic denervation in the rat striatum. Molecular Brain Research. 76(2). 306–314. 19 indexed citations
10.
Gómez‐Gómez, Lourdes, Mari‐Paz Rubio, J. J. Vázquez, et al.. (1996). Chromosome 17 Allelic Loss and NF1-GRD Mutations Do Not Play a Significant Role as Molecular Mechanisms Leading to Melanoma Tumorigenesis. Journal of Investigative Dermatology. 106(3). 432–436. 9 indexed citations
11.
Flores, J F, Frank G. Haluska, Javier S. Castresana, et al.. (1996). Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.. PubMed. 56(21). 5023–32. 117 indexed citations
12.
Castresana, Javier S., et al.. (1995). Detection of TP53 gene mutations in human sarcomas. European Journal of Cancer. 31(5). 735–738. 33 indexed citations
13.
Ueki, Keisuke, Mari‐Paz Rubio, Vijaya Ramesh, et al.. (1994). MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Human Molecular Genetics. 3(10). 1841–1845. 87 indexed citations
14.
Schneider, J., Mari‐Paz Rubio, F.J. Rodríguez‐Escudero, Bernd R. Seizinger, & Javier S. Castresana. (1994). Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: Comparison with the results of immunohistochemistry. European Journal of Cancer. 30(4). 504–508. 24 indexed citations
15.
Rubio, Mari‐Paz, et al.. (1994). P-glycoprotein, HER-2/neu, and Mutant p53 Expression in Human Gynecologic Tumors. JNCI Journal of the National Cancer Institute. 86(11). 850–855. 56 indexed citations
16.
Rubio, Mari‐Paz, Vijaya Ramesh, Mia MacCollin, et al.. (1994). Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.. PubMed. 54(1). 45–7. 121 indexed citations
17.
Louis, David N., Andreas von Deimling, Richard Y. Chung, et al.. (1993). Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors. Journal of Neuropathology & Experimental Neurology. 52(1). 31–38. 195 indexed citations
18.
Rubio, Mari‐Paz, Andreas von Deimling, David W. Yandell, et al.. (1993). Accumulation of wild type p53 protein in human astrocytomas.. PubMed. 53(15). 3465–7. 119 indexed citations
19.
Castresana, Javier S., Mari‐Paz Rubio, J. J. Vázquez, et al.. (1993). Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. International Journal of Cancer. 55(4). 562–565. 89 indexed citations
20.
Louis, David N., et al.. (1993). Molecular Genetics of Pediatric Brain Stem Gliomas. Application of PCR Techniques to Small and Archival Brain Tumor Specimens. Journal of Neuropathology & Experimental Neurology. 52(5). 507–515. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026